Pediatric Migraine

Qualitative Analysis of Visual Symptoms in Childhood Migraine

Qualitative Analysis of Visual Symptoms in Childhood Migraine

By

Investigators examined the characteristics of visual symptoms during migraine attacks in children and adolescents.

Managing Pediatric Migraine: Current Therapies and Future Directions

Managing Pediatric Migraine: Current Therapies and Future Directions

By

Migraine is highly prevalent in children and adolescents, affecting almost 10% of children between 5 and 15 years old and 30% of adolescents between 15 and 19 years old.

Pseudotumor Cerebri Syndrome vs Migraine in Children: Differential Diagnosis

Pseudotumor Cerebri Syndrome vs Migraine in Children: Differential Diagnosis

By

The illustration of headache symptoms through drawings may help clinicians distinguish between pseudotumor cerebri syndrome and migraine in pediatric patients.

Using ICHD-3 beta vs ICHD-II to Diagnose Migraine With Typical Aura in Children

Using ICHD-3 beta vs ICHD-II to Diagnose Migraine With Typical Aura in Children

By

Use of the International Classification of Headache Disorders 3 (ICHD-3) beta classification criteria vs ICHD-II may result in an increased percentage of pediatric patients diagnosed with migraine with typical aura.

Occipital Nerve Block, an Effective Option for Pediatric Headache

Occipital Nerve Block, an Effective Option for Pediatric Headache

By

Peripheral nerve blocks for pediatric headache treatment are associated with significant benefit and minimal risk.

Incidental Findings on Brain MRI for Pediatric Headache

Incidental Findings on Brain MRI for Pediatric Headache

By

Although a range of incidental findings may be observed on MRI obtained in pediatric headache, they are rarely indicative of a serious underlying condition.

OnabotulinumtoxinA Injections Reduce Chronic Migraine in Pediatric Patients

OnabotulinumtoxinA Injections Reduce Chronic Migraine in Pediatric Patients

By

Frequent onabotulinumtoxinA injections during a 5-year period provide effective analgesic benefits in pediatric patients presenting with chronic migraine.

Pediatric Episodic Syndrome Linked to Migraine: Expert Q&A (Part II)

Pediatric Episodic Syndrome Linked to Migraine: Expert Q&A (Part II)

By

Almost 10% of pediatric patients with migraine also experience various episodic syndromes. Physicians Amy Gelfand and Diana Lebron weigh in on what to look for to help you find the right diagnosis.

Pediatric Episodic Syndromes Linked to Migraines: Signs and Symptoms (Part I)

Pediatric Episodic Syndromes Linked to Migraines: Signs and Symptoms (Part I)

By

Nearly 10% of pediatric patients with migraines also experience episodic syndromes involving symptoms such as vomiting, vertigo, or gastrointestinal pain.

Allodynia and Pericranial Tenderness Highly Prevalent in Pediatric Patients With Migraine

Allodynia and Pericranial Tenderness Highly Prevalent in Pediatric Patients With Migraine

By

Symptoms associated with central sensitization are common in children and adolescents with migraine.

Attachment Insecurity Mediates Anxiety in Pediatric Migraine

Attachment Insecurity Mediates Anxiety in Pediatric Migraine

By

Attachment insecurity may amplify anxiety in children and adolescents with migraine without aura.

Nasal Nerve Block for Migraine Relief in Children

Nasal Nerve Block for Migraine Relief in Children

A nasal nerve block may be an effective pain relief method for children with migraines.

Botox for Pediatric Refractory Migraine?

Botox for Pediatric Refractory Migraine?

By

Botox treatment led to significant improvement in the intensity and frequency of migraine.

Sign Up for Free e-Newsletters